Enhancement of International Dermatologists' Pigmented Skin Lesion Biopsy Decisions Following Dermoscopy with Subsequent Integration of Multispectral Digital Skin Lesion Analysis
- PMID: 27672411
- PMCID: PMC5023003
Enhancement of International Dermatologists' Pigmented Skin Lesion Biopsy Decisions Following Dermoscopy with Subsequent Integration of Multispectral Digital Skin Lesion Analysis
Abstract
Background: Early detection and subsequent management of melanoma are critical for patient survival. New technologies have been developed to augment clinician analysis of suspicious pigmented skin lesions.
Objective: To determine how information provided by a multispectral digital skin lesion analysis device affects the biopsy decisions of international dermatologists following clinical and dermoscopic pigmented skin lesion evaluation.
Methods: Participants at a dermoscopy conference in Vienna, Austria, were shown 12 clinical and dermoscopic images of pigmented skin lesions (2 melanomas in situ, 3 invasive melanomas, and 7 low-grade dysplastic nevi) previously analyzed by multispectral digital skin lesion analysis. Participants were asked if they would biopsy the lesion based on clinical images, again after observing high-resolution dermoscopy images, and again when subsequently shown multispectral digital skin lesion analysis information.
Results: Data were analyzed from a total of 70 international dermatologists. Overall, sensitivity was 58 percent after clinical evaluation (C) and 59 percent post-dermoscopy (D), but 74 percent after multispectral digital skin lesion analysis. Participant specificity was 56 percent (C) decreasing to 51 percent (D), but increasing to 61 percent with multispectral digital skin lesion analysis. Diagnostic accuracy was 57 percent (C) decreasing to 54 percent (D), but increasing to 67 percent for dermatologists after integrating the multispectral digital skin lesion analysis data into the biopsy decision. The overall number of lesions biopsied increased from 50 percent (C) to 53 percent (D), rising to 54 percent after multispectral digital skin lesion analysis.
Conclusion: Decisions to biopsy melanocytic lesions were more sensitive and specific when multispectral digital skin lesion analysis information was provided with no significant increase in the number of biopsies recommended. Providing multispectral digital skin lesion analysis data may lead to additional improvement in biopsy accuracy with a concomitant decrease in the number of nonessential biopsies for pigmented skin lesions even after dermoscopic evaluation.
Figures
Similar articles
-
Impact of Guidance Provided by a Multispectral Digital Skin Lesion Analysis Device Following Dermoscopy on Decisions to Biopsy Atypical Melanocytic Lesions.J Clin Aesthet Dermatol. 2015 Sep;8(9):21-4. J Clin Aesthet Dermatol. 2015. PMID: 26430487 Free PMC article.
-
The Impact of Multispectral Digital Skin Lesion Analysis on German Dermatologist Decisions to Biopsy Atypical Pigmented Lesions with Clinical Characteristics of Melanoma.J Clin Aesthet Dermatol. 2015 Oct;8(10):27-9. J Clin Aesthet Dermatol. 2015. PMID: 26557216 Free PMC article.
-
Assessment of a Diagnostic Predictive Probability Model Provided by a Multispectral Digital Skin Lesion Analysis Device for Melanoma and Other High-risk Pigmented Lesions and its Impact on Biopsy Decisions.J Clin Aesthet Dermatol. 2014 Dec;7(12):16-8. J Clin Aesthet Dermatol. 2014. PMID: 25584133 Free PMC article.
-
Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.Acta Dermatovenerol Croat. 2018 Apr;26(1):64-67. Acta Dermatovenerol Croat. 2018. PMID: 29782304 Review.
-
Enhanced melanoma diagnosis with multispectral digital skin lesion analysis.Cutis. 2018 May;101(5):338-340. Cutis. 2018. PMID: 29894523 Review.
Cited by
-
Dermoscopy, with and without visual inspection, for diagnosing melanoma in adults.Cochrane Database Syst Rev. 2018 Dec 4;12(12):CD011902. doi: 10.1002/14651858.CD011902.pub2. Cochrane Database Syst Rev. 2018. PMID: 30521682 Free PMC article.
-
Visual inspection and dermoscopy, alone or in combination, for diagnosing keratinocyte skin cancers in adults.Cochrane Database Syst Rev. 2018 Dec 4;12(12):CD011901. doi: 10.1002/14651858.CD011901.pub2. Cochrane Database Syst Rev. 2018. PMID: 30521688 Free PMC article.
-
Visual inspection for diagnosing cutaneous melanoma in adults.Cochrane Database Syst Rev. 2018 Dec 4;12(12):CD013194. doi: 10.1002/14651858.CD013194. Cochrane Database Syst Rev. 2018. PMID: 30521684 Free PMC article.
-
Computer-assisted diagnosis techniques (dermoscopy and spectroscopy-based) for diagnosing skin cancer in adults.Cochrane Database Syst Rev. 2018 Dec 4;12(12):CD013186. doi: 10.1002/14651858.CD013186. Cochrane Database Syst Rev. 2018. PMID: 30521691 Free PMC article.
References
-
- Rigel DS, Russak J, Friedman R. The evolution of melanoma diagnosis: 25 years beyond the ABCDs. CA Cancer J Clin. 2010;60:301–316. - PubMed
-
- JAMA. 1992;268:1314–1319. NIH Consensus Conference: Diagnosis and treatment of early melanoma. - PubMed
-
- Gutkowicz-Krusin D, Elbaum M, Jacobs A, et al. Precision of automatic measurements of pigmented skin lesion parameters with a MelaFind multispectral digital dermoscope. Melanoma Res. 2000;10:563–570. - PubMed
-
- Winkelmann RR, Cockerell CJ, Sober AJ, et al. Integrating evolving technologies into the diagnosis, assessment, and initial management of melanoma: expert panel review. Dermatol Clin. (Submitted 2016).
-
- Elbaum M, Kopf AW, Rabinovitz HS, et al. Automatic differentiation of melanoma and melanocytic nevi with multispectral digital dermoscopy: a feasibility study. J Am Acad Dermatol. 2001;44:207–218. - PubMed
LinkOut - more resources
Full Text Sources